Volume | 234,550 |
|
|||||
News | - | ||||||
Day High | 10.00 | Low High |
|||||
Day Low | 9.51 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Inovio Pharmaceuticals Inc New | INO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.98 | 9.51 | 10.00 | 9.59 | 10.02 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
3,432 | 234,550 | US$ 9.69 | US$ 2,272,319 | - | 3.888 - 14.748 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:28:40 | 1 | US$ 9.57 | USD |
Inovio Pharmaceuticals Inc New Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
224.12M | 23.37M | - | 832k | -135.12M | -5.78 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Inovio Pharmaceuticals News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.81 | 10.46 | 9.51 | 10.11 | 216,279 | -0.22 | -2.24% |
1 Month | 11.15 | 13.44 | 9.51 | 11.17 | 327,758 | -1.56 | -13.99% |
3 Months | 10.79 | 14.748 | 8.96 | 11.45 | 350,220 | -1.20 | -11.12% |
6 Months | 4.554 | 14.748 | 4.26 | 8.24 | 1,586,422 | 5.04 | 110.58% |
1 Year | 6.78 | 14.748 | 3.888 | 6.27 | 3,372,534 | 2.81 | 41.45% |
3 Years | 96.12 | 123.96 | 3.888 | 32.94 | 4,676,332 | -86.53 | -90.02% |
5 Years | 27.48 | 426.00 | 3.888 | 122.55 | 9,061,643 | -17.89 | -65.10% |
Inovio Pharmaceuticals Description
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. |